Matthew Biegler
Stock Analyst at Oppenheimer
(2.82)
Main Sectors:
Top Industries:
29 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BBOT BridgeBio Oncology | Initiates Coverage On: Outperform | 23 | 11.7 | 96.58% | 1 | Sep 4, 2025 | |
OLMA Olema Pharmaceutical... | Maintains: Outperform | 22 22 | 9.51 | 131.34% | 7 | Sep 3, 2025 | |
ACRV Acrivon Therapeutics | Maintains: Outperform | 9 8 | 1.66 | 381.93% | 4 | Aug 14, 2025 | |
NRIX Nurix Therapeutics | Reiterates: Outperform | 32 30 | 8.93 | 235.95% | 2 | Jul 31, 2025 | |
CTMX CytomX Therapeutics | Initiates Coverage On: Outperform | 7 | 2.9 | 141.38% | 1 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 10 9 | 1.25 | 620% | 2 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 12 | 11.12 | 7.91% | 5 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 160 160 | 33.62 | 375.91% | 7 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 45 | 8.27 | 444.14% | 5 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 105 115 | 112.1 | 2.59% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 53 53 | 26.83 | 97.54% | 5 | Oct 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 33 | 12.97 | 154.43% | 6 | Sep 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 20 20 | 1.55 | 1190.32% | 7 | Sep 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 6 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 114 125 | n/a | n/a | 5 | Jul 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 4 | Jul 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 14 | 8.84 | 58.37% | 5 | May 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 1 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 44 | n/a | n/a | 1 | Mar 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 5 | Feb 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 2 | Feb 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 3 | n/a | n/a | 4 | Aug 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1500 450 | n/a | n/a | 5 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | n/a | n/a | 1 | Jun 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Dec 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 2 | Dec 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 520 360 | n/a | n/a | 1 | Nov 30, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Feb 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 115 105 | n/a | n/a | 3 | Jan 21, 2022 |